The burden of multidrug-resistant tuberculosis in children
Authors:
- 1 May 2018
- journal article
- review article
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 22 (5) , 3-6
Abstract
BACKGROUND: Childhood tuberculosis (TB) has historically been neglected, although in recent years there has been increased focus on this problem. In particular, there have been two efforts to estimate the burden of pediatric multidrug-resistant TB (MDR-TB). METHODS: We review current estimates of the global incidence of pediatric MDR-TB disease. We then combine pediatric MDR-TB treatment data from the World Health Organization and recently published case fatality ratio estimates for children with TB to produce mortality estimates for children with MDR-TB. Finally, we combine treatment data and estimates of household size and disease risk to estimate how many children could be treated for probable or confirmed MDR-TB by carrying out household contact investigations around adult MDR-TB patients. RESULTS: Between 25 000 and 32 000 children develop MDR-TB disease annually, accounting for around 3% of all pediatric TB cases. Only 3–4% of these children are likely to receive MDR-TB treatment. We estimate that around 21% of children who develop MDR-TB disease will die. Carrying out household contact investigations around adult MDR-TB patients could find an estimated 12 times as many pediatric MDR-TB cases as are currently being identified. DISCUSSION: The diagnosis and treatment of children with MDR-TB needs to be prioritized by TB programs.Keywords
This publication has 16 references indexed in Scilit:
- Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2017
- Global burden of drug-resistant tuberculosis in children: a mathematical modelling studyThe Lancet Infectious Diseases, 2016
- Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatmentThe Lancet, 2015
- Data for action: collection and use of local data to end tuberculosisThe Lancet, 2015
- Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimatesThe Lancet, 2014
- Yield of Contact Investigations in Households of Patients With Drug-Resistant Tuberculosis: Systematic Review and Meta-AnalysisClinical Infectious Diseases, 2013
- Drug-resistant tuberculosis: time for visionary political leadershipThe Lancet Infectious Diseases, 2013
- Contact investigation for tuberculosis: a systematic review and meta-analysisEuropean Respiratory Journal, 2012
- Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Closing the Policy-Practice Gap in the Management of Child Contacts of Tuberculosis Cases in Developing CountriesPLOS Medicine, 2011